Title: STD LABORATORY METHODS
1STD LABORATORY METHODS
2Disclaimer This is not a lab course. The
participant will not be trained as a lab
technician in this course.
3Importance of Information
- Answer questions
- Solve problems for persons with some laboratory
experience - Better understanding of lab results
- Limitations
- Interpertations
4How Good is a Test?
5CHD Testing
- Central Laboratory
- 600 GC culture / mo
- 475 GC DNA Probe / mo
- 350 GC Amplified / mo
- 850 Chlamydia DNA / mo
- 350 Chlamydia Amp / mo
- 700 VDRL / mo
- 500 HIV / mo
Clinic Laboratory 6800 Gramstains / yr 2800 Wet
Preps / yr 200 Darkfields / yr
6N. gonorrhea
7Gonorrhea Methods
Sensitivity Female Male
- Gram stain 50 95 - 98
- Culture 80 - 90 95 - 98
- Direct detection 80 - 90 90 - 95
- Amplified direct 98.5 97
or molecular technology -
8Gram Stain
- History
- Classic microbiology tool
- How does it work?
9Exudate Gram Stain
- Specimen collection
- Smear preparation
- Fixation
- Staining
10Application to GC Diagnosis
- Uro-genital specimens only
- Primarily male
- Female - purulent exudate from cervical OS or
urethral orifice
11(No Transcript)
12Photomicrograph
13GonorrheaCriteria for Positive
- Gram negative diplococci
- Typical cellular morphology
- Intracellular PMN
- Uro-genital source
14Gonorrhea Culture
15Gonorrhea Inoculation
- TM / MTM / ML plates
- N / Z pattern
- CO2 requirement
- Pre incubation _at_ 35º
16Inoculation Picture
17Gonorrhea
- Incubation conditions
- Identification
18Gonorrhea
Oxidase Positive
19Culture Gram Stain
20Gonorrhea
- Incubation conditions
- Identification
- Confirmation
21GC Confirmation
Uro - genital Throat Rectal
N. gonorrhea 98 N. meningitidis N.
meningitidis N. meningitidis N.
lactamica N. lactamica N. lactamica
B. catarrhalis N. gonorrhea
N. gonorrhea
22GonorrheaConfirmatory Methods
- Sugar fermentation
- Rapid sugars
- Co-agglutination
- DNA probe
23GonorrheaConfirmatory Methods
GonoGen
Gonocheck II
Remel NET
API Quad Firm
24N.gonorrhea N.meningitidis
Rapid Sugar
25Gonorrhea
- GISP Antibiotic Resistance
- 26 sites
- Monthly isolates
- Resistance trends
26GonorrheaDirect Detection Assays
27GonorrheaDirect Detection
- Specimen sources
- Instrumentation/ automation
- Confirmation
28Gonorrhea Molecular Technologies
- Signal Amplified Assays
- Digene
29Gonorrhea Molecular Technologies
Target Amplified Assays
30Amplified Specimens
- PCR-female swab, male swab urine
- TMA-female urine swab, male urine swab,
vaginal swab - SDA-female urine swab, male urine swab
31Summary
- Expensive vs. greater sensitivity
- Amplified technology not for medical legal (yet)
- Only one confirmatory procedure
- Approved specimens vary by manufacturer
- False positive potential
- Amplification inhibition
32Biology of Chlamydia
33Chlamydia Life Cycle
34ChlamydiaSensitivity by Method
Method Percent
- Rapid tests 52 - 85 Male
- 65 - 85 Female
- Tissue culture 70 - 85
- EIA (ELISA) 80 - 92
- male urine 76
- DNA probe 80 - 96
- DFA 80 - 96
35ChlamydiaEB Detection Limits
- Molecular technology 1 - 10
- Tissue culture 5 - 100
- DFA 10 - 500
- Direct probe 500 - 10,000
- EIA 5,000 - 100,000
- Rapid tests 100,000
36ChlamydiaCulture
- Methods
- tissue culture vials
- shell vials
- Incubation - 3-7 days
- Experienced personnel
required - Confirmation
37ChlamydiaTissue Culture
Shell vial
38ChlamydiaMolecular Technologies
39ChlamydiaMolecular Technologies
Target Amplified Assays
- PCR Plasmid DNA
- TMA Ribosomal RNA
- SDA Plasmid DNA
40PCR by Roche (cont.)
- Sensitivity
- Female urine 86
- Female swab 95
- Male urine 88
- Male swab 97
41TMA by Gen Probe (cont.)
- Sensitivity
- Female urine 83
- Female swab 99
- Male urine 93
- Male swab 98
42SDA by Becton Dickinson (cont.)
- Sensitivity
- Female urine 80
- Female swab 92
- Male urine 90
- Male swab 94
43Amplified Specimens
- PCR-female swab, male swab urine
- TMA-female urine swab, male urine swab,
vaginal swab - SDA-female urine swab, male urine swab
44Summary
- Expensive vs. greater sensitivity
- Amplified technology not for medical legal (yet)
- Only one confirmatory procedure
- Approved specimens vary by manufacturer
- False positive potential
- Amplification inhibition
45Future Discussion Points
- Negative gray zone testing
- Pooling
46Vaginosis
47Prevalence and Recognition
- Incidence range 5 in general population up to
64 in patients visiting STD Clinics - Only 3 of women recognize classic symptoms of
BV
- Nyirijesy, Paul MD Contemporary OB / GYN , Nov
2000 - Ferris, DG, J. Fam. Pract. 1996 42595-600
48Testing Methods
- POL Tests
- Culture
- Microscopy
- DNA Probe
49POL Tests
- G. vaginalis peptidase activity slide test
- ( also Mobiluncus spp.)
- pH and Amine detection ( pH gt 4.7 )
- BV Blue test for sialidase activity gt7.8 U
- ( Gardnerella, Bacteroides, Prevotella,
Mobiluncus )
50Culture
- Yeast
- Trichomonas
- In Pouch
- Trichosel
- BV Not Recommended
51Wet Mount
52Wet Mount
- Specimen collection handling
53Wet Mount
- Organisms of interest
- Yeast
- Clue cells (Gardnerella etc)
- Trichomonas
54Wet Mount
- Microscopy
- Focus
- Selecting a field
- Lighting
- Brightfield, Darkfield, Phase
55Wet Mount
- Yeast
- Budding
- Pseudohyphae
- Culture
56Wet Mount
- Clue Cells
- Gardnerella vaginalis
- Stippled epithelial cells
- whiff test using KOH
- amine odor
57(No Transcript)
58Wet Mount
- Trichomonas
- Motility
- Temperature
- pH sensitive
- Culturable
59(No Transcript)
60Wet Mount
- Motility needed for diagnosis
61DNA Probe
- BD Affirm
- All three Organisms of interest
62Regulatory Issues
- CLIA
- EPA Infectious waste
- OSHA Bloodborne pathogens
63STDLaboratory Methods
- For More Information
- Cincinnati STD/HIV
- Prevention Training Center
- 1-800-459-2820
64STD LABORATORY METHODS
Has been brought to you by Cincinnati STD/HIV
Prevention Training Center